Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

Programmed cell death 1 (PD-1) inhibitor-related pneumonitis is a rare but clinically serious and potentially life-threatening adverse event. Little is known about its incidence across different tumor types and treatment regimens.To compare the incidence of PD-1 inhibitor-related pneumonitis among different tumor types and therapeutic regimens.A PubMed search through November 10, 2015, and a review of references from relevant articles. For the...